saving the lives of liver disease patients
Versantis is a preclinical stage pharmaceutical company focused on rare liver diseases. We are committed to the development of life-saving therapies for acute liver failure patients for which the current available care is not satisfactory.
A life-saving therapy
Versantis’ lead product candidate, VS-01, is the first safe and effective treatment for acute-on-chronic liver failure (ACLF), a life-threatening condition of high unmet medical need. The mortality of ACLF patients is alarming due to multi-organ failures resulting in a dangerous accumulation of toxins in the blood. The versatile mechanism of action of VS-01 can support simultaneously the affected organs (liver, kidneys, brain) and clear these toxins from the body.